Here you will find further information on specific topics.
Information for patients
Treatment of light skin cancer
The new nuclear medicine method R-SCT (Rhenium Skin Cancer Therapy) for the treatment of light skin cancer uses radioactive Rhenium 188. Cancer cells that are no more than three millimetres deep can thus be treated in 98 per cent of the cases in a single, painless, and non-invasive procedure with aesthetic results. DSD Pharma is the first and only distributor in Austria to supply the innovative R-SCT to nuclear medicine departments.
Taking thyroid hormones in resorption disorders
In the case of absorption disorders, only part of the active ingredient in the drug that is being taken can be absorbed into the blood. The desired effect cannot be achieved as a result, or can only be achieved to a limited extent. This may require a higher dose of the drug.